Estadísticas
Número total de visitas
| Visualizaciones | |
|---|---|
| Randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of Lacticaseibacillus rhamnosus CRL1505 in the prevention of upper respiratory tract infections in a healthy pediatric population | 669 |
Visitas al mes
| marzo 2026 | abril 2026 | mayo 2026 | junio 2026 | julio 2026 | agosto 2026 | septiembre 2026 | |
|---|---|---|---|---|---|---|---|
| Randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of Lacticaseibacillus rhamnosus CRL1505 in the prevention of upper respiratory tract infections in a healthy pediatric population | 28 | 41 | 59 | 55 | 43 | 49 | 36 |
Visitas al fichero
| Visualizaciones | |
|---|---|
| Registro IRESP.PROB 2.pdf | 235 |
Países con más visualizaciones
| Visualizaciones | |
|---|---|
| Estados Unidos | 197 |
| Alemania | 85 |
| Singapur | 81 |
| Hong Kong | 45 |
| Brasil | 41 |
| Irlanda | 23 |
| Reino Unido | 22 |
| Vietnam | 20 |
| España | 17 |
| México | 15 |
Ciudades con más visualizaciones
| Visualizaciones | |
|---|---|
| Frankfurt am Main | 81 |
| Ashburn | 71 |
| Hong Kong | 43 |
| Council Bluffs | 24 |
| Dublin | 23 |
| San Jose | 17 |
| Singapore | 14 |
| Santafé | 10 |
| Hanoi | 9 |
| Mexico City | 8 |
